Annette Bak, Ph.D.

Head of Advanced Drug Delivery at AstraZeneca

Speaker

Annette Bak, Ph.D., MBA leads Advanced Drug Delivery (ADD) at Astra Zeneca and serves on the Pharmaceutical Sciences leadership team. Advanced Drug Delivery has the mission to transform diverse modalities, small molecules and new modalities alike, into investigational medicines and is a global organization based in Sweden, UK, and US.

Since joining AstraZeneca in 2016, Annette has been instrumental in delivering a variety of synthetic modality and mRNA drug delivery systems and formulations for preclinical & clinical studies. She has also built delivery chemistry and intracellular drug delivery capabilities within ADD.

Annette previously worked for Amgen and Merck in the US with responsibility for small molecule and peptide formulations, building outsourcing partnerships in China, in licensing and partnership evaluations, and contributing to getting small molecule therapies to the market.

Annette has published more than 50 articles, has more than 50 invited presentations, and serves on the editorial board for the Journal of Pharmaceutical Sciences and Molecular Pharmaceutics. She holds several patents for pharmaceutical technologies enabling drug delivery of small molecules and biologics.

A key volunteer in American Association of Pharmaceutical Scientists (AAPS). She was the 2022 president for the association and responsible for leading implementation of the 2021-2025 strategic plan and ensuring that the AAPS communities are thriving. Annette was the 2020 co-recipient of the AAPS Alice E Till Women in Pharmaceutical Science Recognition, honoring women who has made significant contributions to the to the mentorship, advancement, and support of women in the pharmaceutical sciences